- 专利标题： Carbon-neutral and carbon-positive photorespiration bypass routes supporting higher photosynthetic rate and yield
-
申请号： US15737558申请日： 2016-06-22
-
公开(公告)号： US10781456B2公开(公告)日： 2020-09-22
- 发明人: Arren Bar-Even , Tobias Erb , Steffen Lindner , Philippe Marliere , Dan S. Tawfik
- 申请人： Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. , Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
- 代理机构： Perdue IP Law, APC
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@366f806b com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@31eaa9e1
- 国际申请： PCT/EP2016/064420 WO 20160622
- 国际公布： WO2016/207219 WO 20161229
- 主分类号： C12N15/82
- IPC分类号： C12N15/82
摘要：
The present invention relates to an organism, a tissue, a cell or an organelle expressing enzymes which allow the conversion of 2-phosphoglycolate (2-PG; also known as glycolate 2-phosphate,) into an intermediate compound of the Calvin-Benson-Bassham Cycle (CBBC) without releasing CO2. The organism, tissue, cell or organelle of the invention may be genetically engineered, transgenic and/or transplastomic so as to express at least one enzyme which is involved in this conversion. The present invention further relates to an organism, tissue, cell or organelle which comprises/expresses at least one enzyme which is involved in this conversion. The present invention further relates to a method for producing an organism, tissue, cell or organelle of the invention. The present invention further relates to a method of enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2. The present invention further relates to the use of an organism, tissue, cell or organelle of the invention for enzymatically converting 2-PG into an intermediate compound of the CBBC without releasing CO2.